News

A patchwork of regulations challenges manufacturers and distributors in the US

Healthcare is among the targeted industries for the multi-use facility

PIM will eventually forge links from manufacturer to patient

‘End to end evidence management’ will affect both clinical and commercial activities

A market leader in pharmaceutical packaging machinery and systems

PBMs, wholesalers and insurers lose over $20 billion in stock value on day of announcement

Administrator Gottlieb warns against 'the proliferation and illegal marketing of unapproved CBD-containing products with unproven medical claims'

Newly formed company will create a marketplace where individuals assert ownership of their personal data

Today's smart, advanced self-injectable devices aim to provide therapeutic value to patient and physicians, and commercial value to the drug makers and payers

New routes, and a new operational system

JFK site will serve as a Northeast US hub

Adents NovaTrack will run on Microsoft’s Azure Intelligent Cloud

Participants hear about USP guidance updates, industry best practices in cold chain

Q Products touts its blankets as an alternative to reefer containers

DIANA Awards for best product launches go to Alkermes and Mylan

Addition to its OCE platform enables collaboration between clients, agencies, sales ops

Will a combination of better diagnosis resources and cost cutting lead to better patient outcomes?

Data are down for 2016-7, but still relatively high compared to prior years; UPDATED

Center for Safe Internet Pharmacies builds a coalition to help families; looks into the ‘dark web’

Machine learning offers business knowledge based on the data that marketers and sales teams generate

Big Data and AI will bring value beyond compliance

Traceability will lead to better pharma supply chains and ultimately, a better social environment

A 2017 postponement makes 2018 the key year for serializing US products; authentication makes a comeback, and cargo security goes digital

Responsive. Flexible. Data-Driven.

An ‘alternative pathway’ to FDA’s existing expanded access programs?